CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market sale SILVERNAIL LAUREN P sold 2,612 shares at $13.53 ($35,352)
- 4 Open-market buy Director bought 40,562 shares at $19.25 ($780,819)
- 4 Open-market buy Director bought 628,536 shares at $19.25 ($12,099,318)
- 4 Open-market sale 10% owner sold 5,307,940 shares at $19.25 ($102,177,845)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 16,000 shares at an average $12.58 ($201,204)
- 4 Open-market buy Director bought 3,000 shares at $12.77 ($38,300)
- 4 Open-market buy Director bought 7,800 shares at $13.04 ($101,689)
- 4 Open-market buy Director bought 295,024 shares at $14.00 ($4,130,336)
- 4 Open-market buy Director bought 6,347 shares at $14.00 ($88,858)
- 4 Open-market sale 10% owner sold 573,888 shares at $14.00 ($8,034,432)
Page 11 of 13 · 252 filings